Adial Pharmaceuticals (ADIL) Stock: Buy, Sell, or Hold?
ADIL - Adial Pharmaceuticals, Inc
$4.22
0.11 (2.68%)
â˛
5d:
+34.39%
30d:
+4.46%
90d:
+51.8%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 12, 2026
19d
Get Alerted When ADIL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ADIL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ADIL is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ADIL is currently trading at $4.22, which is considered fair relative to its 30-day fair value range of $3.56 to $4.67.
Technical Outlook: Technically, ADIL is in a uptrend. Immediate support is located at $3.00, while resistance sits at $4.41.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.33 (+97.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADIL is in a uptrend. Immediate support is located at $3.00, while resistance sits at $4.41.
Market Sentiment: The stock scores a mixed 54/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.33 (+97.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$3.56 -
$4.67
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (54/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 97.5% below Wall St target ($8.33)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.56 -
$4.67
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.00
Resistance Level
$4.41
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.57
Wall Street Target
$8.33
(+97.5%)
Share & Embed Analysis
Last updated: October 23, 2026 6:00 AM ET
Data refreshes hourly during market hours. Next update: 7:00 AM
Data refreshes hourly during market hours. Next update: 7:00 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADIL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 61 BUY |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$686 | 62 BUY |
|
CGON
CG Oncology, Inc. CommonâĻ |
STRONG BUY
15 analysts |
$91 | 64 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 57 HOLD |
